The similar effects of the two inhibitors on gene expression in tumor glial cell populations likely reflect on-target pathway effects in tumor cells regardless of their Nf1 status, as cells with Nf1 knockout are a minority in this model (Wu et al, 2008). Here, NF1 is linked to neoplasm.